TwinBeech Capital’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
TwinBeech Capital's EWTX Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 25,800 shares worth $1.05M. The stake represents 0.24% of the portfolio and ranks #125 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in EWTX as recently as Q2 2025.
TwinBeech Capital first reported a position in EWTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.22M in Q1 2025. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- TwinBeech Capital held 25,800 shares of Edgewise Therapeutics worth $1.05M as of Q3 2026.
- Edgewise Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Edgewise Therapeutics made up 0.24% of TwinBeech Capital's portfolio in Q3 2026, its #125 holding.
- TwinBeech Capital first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 3 quarters since.
- TwinBeech Capital's Edgewise Therapeutics position peaked at $2.22M in Q1 2025.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.